Considerations in the Management of Patients With Philadelphia Chromosome–Positive Chronic Myeloid Leukemia Receiving Tyrosine Kinase Inhibitor Therapy

פריטים דומים

• Role of Tyrosine Kinase Inhibitors in the Management of Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia
  מאת: Mathisen, Michael S., et al.
  יצא לאור: (2011)
• Outcomes of Venetoclax and BCR-ABL Tyrosine Kinase Inhibitor Combinations in Patients with Philadelphia Chromosome-Positive Advanced Myeloid Leukemias
  מאת: Maiti, Abhishek, et al.
  יצא לאור: (2020)
• Tyrosine kinase inhibitor–induced platelet dysfunction in patients with chronic myeloid leukemia
  מאת: Quintás-Cardama, Alfonso, et al.
  יצא לאור: (2009)
• Molecular Monitoring in Chronic Myeloid Leukemia: Response to Tyrosine Kinase Inhibitors and Prognostic Implications
  מאת: Jabbour, Elias, et al.
  יצא לאור: (2008)
• Estimations of the Increasing Prevalence and Plateau Prevalence of Chronic Myeloid Leukemia in the Era of Tyrosine Kinase Inhibitors Therapy
  מאת: Huang, Xuelin, et al.
  יצא לאור: (2012)